Class Action Reminder for NASDAQ: KYTX: Kessler Topaz Meltzer & Check, LLP Reminds Kyverna Therapeutics, Inc. Investors of Securities Fraud Class Action LawsuitGlobeNewsWire • 01/01/25
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Kyverna Therapeutics, Inc. (KYTX) ShareholdersAccesswire • 12/31/24
KYTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Kyverna Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!Accesswire • 12/31/24
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KYTXAccesswire • 12/31/24
Shareholders that Lost Money on Kyverna Therapeutics, Inc. (KYTX) Urged to Join Class Action - Contact Levi & Korsinsky to Learn MoreAccesswire • 12/30/24
Levi & Korsinsky Reminds Kyverna Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 7, 2025 – KYTXGlobeNewsWire • 12/30/24
KYTX Investors Have Opportunity to Lead Kyverna Therapeutics, Inc. Securities Fraud LawsuitPRNewsWire • 12/30/24
Kyverna Therapeutics, Inc. Is Being Sued For Securities Law Violations And Impacted Investors Are Invited To Contact The Schall Law FirmAccesswire • 12/30/24
Class Action Filed Against Kyverna Therapeutics, Inc. (KYTX) - February 7, 2025 Deadline to Join – Contact Levi & KorsinskyAccesswire • 12/30/24
KYTX STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Kyverna Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!Accesswire • 12/30/24
February 7, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against KYTXPRNewsWire • 12/30/24
The Schall Law Firm Urges Shareholders To Take Part In A Securities Fraud Case Against Kyverna Therapeutics IncAccesswire • 12/29/24
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – KYTXGlobeNewsWire • 12/29/24
KYTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Kyverna Therapeutics, Inc. to Contact the Firm Today!Accesswire • 12/29/24
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Kyverna Therapeutics, Inc.(KYTX) ShareholdersAccesswire • 12/29/24
Kyverna Therapeutics, Inc. (KYTX) Investors: February 7, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLPAccesswire • 12/28/24
KYTX INVESTOR NOTICE: Kyverna Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action LawsuitPRNewsWire • 12/28/24
The Schall Law Firm Urges Shareholder Participation In A Securities Fraud Case Against Kyverna Therapeutics IncAccesswire • 12/27/24
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Kyverna Therapeutics, Inc. (KYTX)GlobeNewsWire • 12/27/24
KYTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of Kyverna Therapeutics, Inc. to Contact the Firm Today!Accesswire • 12/27/24
Shareholders that lost money on Kyverna Therapeutics, Inc.(KYTX) Urged to Join Class Action - Contact Levi & Korsinsky to Learn MoreAccesswire • 12/27/24
Faruqi & Faruqi Reminds Kyverna Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 7, 2025 – KYTXGlobeNewsWire • 12/27/24
Kyverna Therapeutics, Inc. Investors with Large Losses Are Encouraged to Contact Shareholder Rights Law Firm Robbins LLP for Information About the KYTX Class Action LawsuitPRNewsWire • 12/27/24
Kyverna Therapeutics, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before February 7, 2025 to Discuss Your Rights – KYTXAccesswire • 12/27/24
Kessler Topaz Meltzer & Check, LLP - Class Action Announcement for Kyverna Therapeutics, Inc. Investors: A Securities Fraud Class Action Lawsuit Was Filed Against Kyverna Therapeutics, Inc.GlobeNewsWire • 12/27/24
